X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

JSPRW

Closed

Jasper Therapeutics Inc

0.1124
-0.0125 (-10.01%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.1249
Day's Range: 0.0963 - 0.1125
Send
When Written:
 
0.1974
Jasper Therapeutics Inc is a biotechnology company that focuses on developing and commercializing novel curative therapies for patients suffering from hematological malignancies and other life-threatening diseases. The company's proprietary platform technology, JSP191, is a first-in-class humanized monoclonal antibody that targets and depletes hematopoietic stem cells (HSCs) in the bone marrow. This technology enables the company to develop potentially curative therapies for patients with a wide range of diseases, including acute myeloid leukemia, myelodysplastic syndromes, sickle cell disease, and beta-thalassemia. The company is headquartered in San Francisco, California, and was founded in 2015.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X